We are live on ! Find out more
HCM

Highbridge Capital Management Portfolio holdings

AUM $3.09B
1-Year Est. Return 31.21%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+31.21%
3 Year Est. Return
+54.52%
5 Year Est. Return
+78.37%
10 Year Est. Return
+191.37%
AUM
$2.45B
AUM Growth
+$45M
Cap. Flow
-$1.31B
Cap. Flow %
-53.22%
Top 10 Hldgs %
43.27%
Holding
417
New
29
Increased
24
Reduced
15
Closed
57

Sector Composition

Rank Sector Weight
1 Communication Services 5.01%
2 Healthcare 1.66%
3 Utilities 0.76%
4 Technology 0.39%
5 Real Estate 0.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RWODR
151
DELISTED
Redwoods Acquisition Corp. Rights
RWODR
$58.1K ﹤0.01%
528,108
+200,000
+61% +$26K
BWAQW
152
DELISTED
Blue World Acquisition Corporation Warrant
BWAQW
0
VCXB.WS
153
DELISTED
10X Capital Venture Acquisition Corp III Warrants
VCXB.WS
0
PGSS.WS
154
DELISTED
Pegasus Digital Mobility Acquisition Corp. Redeemable Warrants
PGSS.WS
0
BWAQR
155
DELISTED
Blue World Acquisition Corporation Right
BWAQR
$55.2K ﹤0.01%
368,070
GHIXW
156
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
0
SWSSW
157
DELISTED
Clean Energy Special Situations Corp. Warrant
SWSSW
0
KCGI.WS
158
DELISTED
Kensington Capital Acquisition Corp. V Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
KCGI.WS
0
OCAXW
159
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
0
BSLKW
160
DELISTED
Bolt Projects Holdings Warrant
BSLKW
0
BHACW
161
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
0
TVGNW icon
162
Tevogen Inc. Warrant
TVGNW
$899K
0
KVACW
163
DELISTED
Keen Vision Acquisition Corp Warrant
KVACW
0
DMYY.WS
164
DELISTED
dMY Squared Technology Group Warrants
DMYY.WS
0
ASBPW
165
Aspire Biopharma Warrant
ASBPW
$449K
0
EVGRW
166
DELISTED
Evergreen Corporation Warrant
EVGRW
0
TBMCR
167
DELISTED
Trailblazer Merger Corporation I Rights
TBMCR
$44.6K ﹤0.01%
437,242
+78,242
+22% +$10.2K
NVACR
168
DELISTED
NorthView Acquisition Corporation Rights
NVACR
$43.6K ﹤0.01%
500,000
+161,141
+48% +$18.5K
ATMVR
169
DELISTED
AlphaVest Acquisition Corp Right
ATMVR
$43K ﹤0.01%
318,624
AERTW
170
Aeries Technology Warrant
AERTW
$891K
0
XAGEW
171
DELISTED
Longevity Health Holdings, Inc. Warrant
XAGEW
0
YOTAR
172
DELISTED
Yotta Acquisition Corporation Right
YOTAR
$40.2K ﹤0.01%
502,193
GDSTR
173
DELISTED
Goldenstone Acquisition Limited Rights
GDSTR
$40.1K ﹤0.01%
603,682
+100,000
+20% +$10.3K
MBTCR
174
DELISTED
Nocturne Acquisition Corporation Right
MBTCR
$39.7K ﹤0.01%
+241,178
New +$38.3K
RFACR
175
DELISTED
RF Acquisition Corp. Rights
RFACR
$38.3K ﹤0.01%
336,968

Similar funds

Highbridge Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Highbridge Capital Management held 417 positions worth $2.45B, up 1.9% from $2.41B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Highbridge Capital Management withdrew a net $1.31B in Q4 2023, closing 57 positions and reducing 15 holdings. Its most notable exit was Seagen Inc. Common Stock, an estimated $19.3M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 5% of assets, up from 4.6% a quarter earlier, followed by Healthcare and Utilities.

Against the trend, Highbridge Capital Management opened a new position in Capri Holdings worth $8.29M.

  • Highbridge Capital Management's largest Q4 2023 buy was Capri Holdings: 165,000 shares worth $8.29M.
  • Highbridge Capital Management added most to Amedisys in Q4 2023, an estimated $14.5M increase.
  • Highbridge Capital Management's biggest Q4 2023 reduction was Brookdale Senior Living Inc. 7.00% Tangible Equity Units, cutting an estimated $14M.
  • Highbridge Capital Management fully exited Seagen Inc. Common Stock in Q4 2023, selling an estimated $19.3M.
  • Highbridge Capital Management's ten largest holdings make up 43% of its $2.45B portfolio in Q4 2023.
  • Highbridge Capital Management opened 29 new positions and closed 57 in Q4 2023.
  • Highbridge Capital Management's portfolio value rose 1.9% quarter-over-quarter to $2.45B.

Based on Highbridge Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.